chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse effects; improperly stored dose administered; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant drugs were not reported.  On 24-MAY-2019, the patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) (lot # R026362, expiration date 15-MAT-2020) (exact dose, frequency, route, site of administration were not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of -9 degrees Celsius (C) to 8C (5.8C) for 17 days. Digital data logger was involved. There were no previous excursions reported. No adverse events were reported.  This is one of two reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA001445:
Pt was admitted from the ED for altered mental status on 4/5/21 after receiving the second dose of vaccine on 3/31/21. Per guidelines, all hospitalizations are reported.
Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 27-year-old female patient (gravida 5, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Miscarriage (Miscarriage OCT 2019 first trimester Miscarriage FEB 2020 first trimester Miscarriage Jun 2020 first trimester) and Thyroid dysfunction in pregnancy in March 2020. Concurrent medical conditions included Seasonal allergy since August 2020. Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) for Seasonal allergy, LEVOTHYROXINE for Thyroid dysfunction in pregnancy, PRENATAL + DHA.    On 01-Mar-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 28-Aug-2020 and the estimated date of delivery was 14-Jun-2021. On 01-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy.  On 01-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2020, Pregnancy test: positive (Positive) Positive. On 29-Jan-2021, Ultrasound foetal: abnormal (abnormal) Marginal cord insertion.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported.  Previous pregnancies reported as live full-term birth on 20-Dec-2014 and other 3 were miscarriage in Oct-2019, Feb-2020 and Jun-2020 respectively. Estimated date of conception was reported in Sep-2020.
Muscle and joint pain in left shoulder; Muscle and joint pain in left shoulder; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7484) via an unspecified route of administration in the left arm on 10Aug2021 at 11:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 20Jul2021 at 12:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 12Aug2021, the patient experienced muscle and joint pain in left shoulder. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 30Aug2021, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the events muscle and joint pain in left shoulder was not recovered at the time of this report.
gen rash, fine;7DEC trunk & T102, 6DEC afeb;
Pain at injection site radiated down into her hand and fingers; Pain at injection site radiated down into her hand and fingers; hand and fingers began; Hand and fingers with a severe, intolerable burning, and pressure sensation; Hand and fingers with a severe, intolerable burning, and pressure sensation; This is a spontaneous report received from a contactable consumer. The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162B2 (BNT162B2), administered in arm left, administration date 20Apr2021 15:00 (Lot number: EW0161) at the age of 46 years as dose 2, single for COVID-19 immunization. Relevant medical history included: "Allergies to nuts" (unspecified if ongoing). Concomitant medication(s) included: SERTRALINE HYDROCHLORIDE; SINGULAIR. Past drug history included: Cipro, reaction(s): "Drug allergy". Vaccination history included: BNT162B2 (DOSE 1; Lot Number: ER8730; left arm; 04:00 PM), administration date: 30Mar2021, when the patient was 46 years old, for COVID-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 20Apr2021 20:00, outcome "recovered", described as "Pain at injection site radiated down into her hand and fingers"; PAIN IN EXTREMITY (non-serious) with onset 20Apr2021 20:00, outcome "recovered", described as "Pain at injection site radiated down into her hand and fingers; hand and fingers began"; BURNING SENSATION (non-serious), DISCOMFORT (non-serious) all with onset 20Apr2021 20:00, outcome "recovered" and all described as "Hand and fingers with a severe, intolerable burning, and pressure sensation". Therapeutic measures were not taken as a result of vaccination site pain, pain in extremity, burning sensation, discomfort.  Additional Information: No other vaccine was administered in four weeks. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination.  No follow-up attempts are possible. No further information is expected.  Follow-up (13Jan2022): Follow-up attempts are completed. No further information is expected.
got sick after; Initial information was received on 28-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer via social media.  This case involves an unknown demographic patient who was got sick after (illness), while the patient received vaccines INFLUENZA VACCINE.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious got sick after (illness) (unknown latency) following the administration of INFLUENZA VACCINE PNEUMOCOCCAL VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  Outcome of the event was unknown.  There will be no information available on the batch number for this case.
High fever > 104, syncopal episode next morning which lasted a few minutes followed by hallucinations.
pt recvd vax while leaving & standing @ doorway c/o SOB, itching & had apparent blotching hives on face, neck, upper arms & chest; MD notified & epi & DPH given;
Snotty, running nose; Dizziness, feeling of falling; Vomiting; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Snotty, running nose), DIZZINESS (Dizziness, feeling of falling) and VOMITING (Vomiting) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Snotty, running nose), DIZZINESS (Dizziness, feeling of falling) and VOMITING (Vomiting). At the time of the report, INFLUENZA LIKE ILLNESS (Snotty, running nose), DIZZINESS (Dizziness, feeling of falling) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment include antihistamine.
This spontaneous report as received from a physician refers to a female patient in her 70's who was a cardiac patient. The patient was vaccinated subcutaneously with 0.65 ml ZOSTAVAX (lot number not reported) "early last week" approximately on 16-OCT-2012. On the same date, the patient was also given an unspecified flu vaccine in the opposite arm. No concomitant medications were reported. "Early last week" approximately on 16-OCT-2012 the patient experienced anaphylactic reaction. She went to an unspecified hospital where she was given epinephrine and was admitted for 24 hours and then released. The hospital report stated that this might have been a reaction to neomycin, but only because that was mentioned in the prescribing information. The outcome of the event was reported as recovered/resolved. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a 12 months old patient. On 01-AUG-2012 the patient was vaccinated with a dose of ZOSTAVAX in error. No product confusion discovered, just medication (nursing) error. No adverse event reported. It was unknown if the patient sought medical attention or not. Additional information has been requested.
Vaccinated for Covid-19 on 1/29/2021 and 2/18/2021.  Symptom onset on 6/10 with fatigue, dizziness, vomiting, abdominal pain, shortness of breath and eventually fever.  Tested positive on 6/13/2021.
This is a spontaneous report from a contactable nurse for a patient enrolled in a Pfizer-sponsored program; this report is in regards to events reported in the patient's past medical history. A currently 23-year-old female patient of an unspecified ethnicity received PREVNAR, via an unspecified route of administration on an unspecified date at single dose for immunisation and CIPRO, via an unspecified route of administration on an unspecified date at an unspecified dose for an unspecified indication. Medical history included allergy to sulfa. The patient's concomitant medications were not reported. On unknown dates, the patient experienced drug allergies to PREVNAR and CIPRO in the form of hives and itching. The action taken in response to the event for PREVNAR was not applicable and for CIPRO was unknown. The clinical outcome of the events, drug allergy, hives, and itching, was unknown.
Prolonged period bleeding and cramping beyond normal frequency before starting birth control. I was on birth control during the time to manage painful cramping, but since getting the shot my next period had cramping that lasted a full week, while before on birth control I had almost no cramping, and before that cramping would only last two days. The bleeding was light also lasted about a full week, while before on birth control it was light for a day or two, and before that would be heavy for about five days.
After getting the vaccine the right side of my face swelled up. They gave me heartburn medicine and Benadryl. I went to ER where I was also given a steroid shot. The swelling lasted two days.
Information has been received from a registered nurse (RN) concerning a 9-year-old Caucasian female with no known allergies who in August 1995, was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) in another office. On 27-FEB-2004 the patient broke out with a mild case of chickenpox. No medical attention was sought. It was reported that the patient's mother treated her with oat (AVEENO BATHS) and diphenhydramine hydrochloride (BENADRYL). Subsequently, the patient recovered from mild case of chickenpox on an unknown date. Additional information is requested.
My daughter screamed uncontrollably for approximately 2 hours after having her 4 month vaccines.  She started this approximately 1-2 hours after having the shots.
Fever 99.5 lasted 24 hours from onset at 2200 on 2-10-21 until 2200 on 2-11-21 Chills/body aches 24 hours from onset at 2200 on 2-10-21 until 2200 on 2-11-21 Redness/swelling/warmth at injection site onset 2-10-21 at 1700 still present as of now 2-12-21 at 1409
Patient was coded and expired Code Blue:  Patient was in dialysis, after 30 minutes his sbp dropped to 60s he was given 4 albumin. Patient who was responsive before that became unresponsive, had seizure like activity, lost pulse and spontaneous breathing.  HD stopped. Code called. Cpr started.  A few minutes into cpr patient  started to profusely bleed - gi bleed and ventilation became very hard., intubation was very difficult and ventilation hard as we suctioned large amounts of aspirated blood. Patient was eventually intubated. More than 8 doses of epi ws given, sodium bicarbonate * 2 given with continuous  cpr. It was mostly PEA with one shockable rhythym. And shock delivered for vfib.   patient continued to profusely bleed, og insertion was not successful and effective ventilation was very tough due to massive aspiration,. Possible variceal rupture with cpr from his cirrhosis is likely scenario.  After 30 minutes of unsuccessful ventilation and acls protocol. Code was stopped.
10 days after MMR developed measles-like rash, low grade fever. No cough, no coupe, no conjunctivitis, no Koplik spots.
Client reported she experienced pain at the site of injection, nausea, anxiety, tachycardia with HR 140 BPM within 12 hours.  On 1/7/20 she experienced severe cervical, clavicle pain with lymph node swelling on right side.  Client reports she was assessed by APRN-NP at the Medical Clinic
Patient received both doses of varicella vaccine as a child per CDC schedule. Had a mild case of shingles that was confirmed by swab at 14 years old (12/17/2018).
pain; This is a spontaneous report from a contactable consumer (patient's wife) via a Pfizer Sponsored Program. A 70-year-old male patient received his first dose bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE) at unknown vaccination age via an unspecified route of administration on 29Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that the patient received the first dose of the COVID-19 vaccine last Friday (29Jan2021), and he is scheduled to receive his "pain shot" this coming Thursday (unspecified date). She asked if it is ok for her husband to receive this injection between the two doses of the vaccine. She inquired if that's okay to take it prior to the second shot. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
Within 24 hrs after the injection, the injection area was hard and swollen at approximately 3" in diameter. Several days after the injection, there was lower back pain that continued to increase until seen in the emergency room on 8/23/21. Informed by Physician in Emergency room that I was suffering from pain due to inflammation near sciatic nerve on the right side. Was asked multiple times if there was anything that could have affected my status and informed staff I received the COVID 19 shot. Checked medical records and statements I made to staff were not documented.   Muscle Relaxors, Morphine, and pain medication were prescribed to assist with pain. Was prescribed Prednisone for 10 days which assisted with most of the swelling. Continuing to have spasms in lower right side of back near sciatic nerve since the COVID shot. This is a continuing issue that I did not have before the shot and I continue to suffer from.
Began 15 minutes after injection: flushing/redness of the face, lasted thirty minutes Began 2 hours after injection: two hives on left upper lip, lasted thirty minutes
She developed fever (tmax of 101.5) and vomiting on the day of vaccines and so far on the day after. Most likely she picked up a viral GI illness however felt it should be reported.
headache, low grade fever up to 100 degrees, chills ,nausea, itching
The month following my second dose of the covid vaccine I noticed that I stated to have a burning sensation when I was going to the bathroom. It would come and go. When it would come back it would get even worse. About two weeks later I started to pass blood and decided to go to my doctor and they escorted me to the emergency room. I was told I had a urinary track infection. They put me on antibiotics and it went away.
rash on chest and back; This case was reported by a consumer and described the occurrence of rash in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st November 2021, the patient received the 1st dose of Shingrix (intramuscular). On 9th November 2021, 8 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The case was self reported by the patient. On 1st November 2021, the patient received 1st dose of Shingrix.  On the day of reporting, the patient developed a rash on her chest and back. The reporter did not wanted to provide any additional information. The reporter did not consent tofollow up.
she can't walk; her ankle, arms, muscles are in pain; her ankle, arms, muscles are in pain; her ankle, arms, muscles are in pain; This is a spontaneous report from a contactable consumer via Pfizer-sponsored program. An 85-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Mar2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included ongoing urinary tract infection. The patient's concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04Mar2021 for COVID-19 immunization and experienced pain and nausea. In Mar2021, the patient can't walk because her ankle, arms, muscles were in pain. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
pt had heaviness to both arms 1NOV95 then numbness to lt hand on 4NOV95 then numbness to rt hand on 5NOV95; on 6NOV95 pt has numbness & heaviness to both arms & hands & encouraged pt to see PMD ASAP
sick to my stomach; body has been hurting so bad; very tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (body has been hurting so bad) and FATIGUE (very tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (body has been hurting so bad) and FATIGUE (very tired). At the time of the report, ABDOMINAL DISCOMFORT (sick to my stomach), MYALGIA (body has been hurting so bad) and FATIGUE (very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not reported.  Treatment Information was not reported.
Red at injection site, hard lump and a red itchy circle with a diameter of about 2.5 inches. Pain, itching and swelling.
1/23/22 pt had a positive COVID test at Medical Center; given IV ABX and steroids; also had Pulmonary Embolus; dc'd to SNF on 1/28/22; comfort care measures only; pt found deceased in nursing home
Has had MMR/V and Varicella both on 4/7/13 this 6 year old female began with typical lesions of varicella that spread by 4/8/13 no fever or any other sxs. Symptomatic care for symptoms advised.
Case number PHEH2016US029283, is an initial spontaneous report received from a nurse on 07 Nov 2016. This report refers to a 59 years old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUCELVAX Quadrivalent (batch number: not reported) at a dose of 0.5 ml, intramuscularly following temperature excursion at 52 Fahrenheit of 01 hour on 18 Oct 2016. Second temperature excursion occurred on 23 Oct 2016, dropped low 06 times to 34 Fahrenheit and lasted 30 minutes each time. Third temperature excursion occurred on 02 Nov 2016, down to 32.2 Fahrenheit three times over the course of 12 Hours. Vaccine had been administered. It was unknown if vaccine was frozen. Nurse did not know which lot was given to which patient. No adverse event was reported following this medication error (incorrect product storage).
This spontaneous report as received from another health professional refers to a patient of unknown age and gender. No medical history or concurrent conditions were reported. It was reported that on 03-SEP-2013, GARDASIL went out of range as it was exposed to 31.2 F for 6 hours. On 05-SEP-2013, the patient was administered with this improperly stored GARDASIL (route of administration unknown) for an unknown indication. Lot number was reported as H021861 with an expiration date of 09-OCT-2015. No adverse effects were reported. No further information was provided. This is one of 16 reports from the same reporter. Additional information has been requested.
Patient reported soreness/inflammation of arm. Could not move arm at all yesterday, now able to move slightly.